Northland Capital Markets Upgrades Intermolecular (IMI) to Outperform

Northland Capital Markets upgraded Intermolecular (NASDAQ: IMI) from Market Perform to Outperform with a price target of $3.00 (from $2.22), saying cash flow break even is in sight.

Analyst Gus Richards commented, "We believe that IMI will achieve cash flow breakeven by the middle of CY16. In addition, IMI's new business model is gaining traction as the company starts to sign new contracts. Lastly, we believe IMI is beginning to see some progress in branching out with a recently signed government contract."

For an analyst ratings summary and ratings history on Intermolecular click here. For more ratings news on Intermolecular click here.

Shares of Intermolecular closed at $1.85 yesterday.

You May Also Be Interested In

• BofA Securities Double Upgrades Sonic Auto (SAH) to Buy
• Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy
• Alphabet (GOOGL) PT Raised to $190 at Mizuho